Literature DB >> 21539577

The effect of cancellous autograft and novel plate design on radiographic healing and postoperative complications in tibial tuberosity advancement for cranial cruciate-deficient canine stifles.

Sarah K Bisgard1, Matthew D Barnhart, Jonathon T Shiroma, Shawn C Kennedy, Eric R Schertel.   

Abstract

OBJECTIVE: To assess the effect of autogenous cancellous bone graft (autograft) and novel plate use on radiographic healing and complications in tibial tuberosity advancement (TTA) for treatment of cranial cruciate ligament (CrCL)-deficient stifles in dogs. STUDY
DESIGN: Prospective clinical study. ANIMALS: Consecutive dogs (n=125) with unilateral CrCL-deficient stifles.
METHODS: Four treatment groups: CPG, conventional plate with autograft; CPNG, conventional plate without autograft; NPG, novel plate with autograft; NPNG, novel plate without autograft were studied. Radiographs from 60 dogs were scored for healing at 6 and 10 weeks postoperatively; all 125 dogs were assessed for radiographic complications. Variables evaluated for relationship with healing scores and radiographic complications were age, weight, sex, cage and plate size, implant type, and graft use.
RESULTS: Dogs with autograft had overall higher healing scores at 6 and 10 weeks. Radiographic complications occurred in 13 dogs (12 minor, 1 major), and were not influenced by graft or novel plate use.
CONCLUSION: Autograft increases healing scores, but was not found to have a significant impact on the rate of complications in TTA. The novel plate was not found to have healing scores or radiographic complication rates significantly different from the conventional plate design. © Copyright 2011 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21539577     DOI: 10.1111/j.1532-950X.2011.00829.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  7 in total

1.  Major complications associated with fork-based and screw-based tibial tuberosity advancement implants: 438 cases.

Authors:  George A Edwards; Giselle Hosgood; Robert B Hancock; W Preston Stubbs; Andrew H Jackson
Journal:  Can Vet J       Date:  2016-04       Impact factor: 1.008

2.  Comparison of three imaging modalities used to evaluate bone healing after tibial tuberosity advancement in cranial cruciate ligament-deficient dogs and comparison of the effect of a gelatinous matrix and a demineralized bone matrix mix on bone healing - a pilot study.

Authors:  Marije Risselada; Matthew D Winter; Daniel D Lewis; Emily Griffith; Antonio Pozzi
Journal:  BMC Vet Res       Date:  2018-05-22       Impact factor: 2.741

3.  Comparison of tension band wiring and other tibial tuberosity advancement techniques for cranial cruciate ligament repair: an experimental study.

Authors:  William McCartney; Ciprian Ober; Maria Benito; Bryan MacDonald
Journal:  Acta Vet Scand       Date:  2019-10-02       Impact factor: 1.695

4.  Preliminary Clinical and Radiographic Evaluation of a Novel Resorbable Implant of Polylactic Acid (PLA) for Tibial Tuberosity Advancement (TTA) by Modified Maquet Technique (MMT).

Authors:  Victoria Valiño-Cultelli; Óscar Varela-López; Antonio González-Cantalapiedra
Journal:  Animals (Basel)       Date:  2021-04-28       Impact factor: 2.752

5.  Incidence of Patellar Desmopathy in the Modified Maquet Technique with and without PRGF.

Authors:  Victoria Valiño-Cultelli; Óscar Varela-López; Antonio González-Cantalapiedra
Journal:  Vet Sci       Date:  2022-04-10

6.  Successful outcome of distal radius non-union after open fracture osteomyelitis treated by external fixation and bone grafting in a cat: case report.

Authors:  Radka Garnoeva; Rumen Roydev; Mehmed Halil
Journal:  Braz J Vet Med       Date:  2022-09-30

7.  Short-term outcomes and complications of 65 cases of porous TTA with flange: a prospective clinical study in dogs.

Authors:  Cristina Bernardi-Villavicencio; Antonio Nicolas Jimenez-Socorro; Concepcion Rojo-Salvador; Javier Robles-Sanmartin; Jesus Rodriguez-Quiros
Journal:  BMC Vet Res       Date:  2020-08-10       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.